Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer

ConclusionThis is the first study which illustrates the value of measuring circulatory miRNA to predict patient-specific toxicities to NAC. These results support the ideology that circulatory miRNAs are biomarkers with utility in predicting chemotherapy toxicity as well as treatment response.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research